@article{1e3046f607cf45c7b8932e09645a7495,
title = "Hepatitis C Virus Infection in Patients With Cancer: Impact on Clinical Trial Enrollment, Selection of Therapy, and Prognosis",
author = "Torres, {Harrys A.} and Pooja Pundhir and Vincent Mallet",
note = "Funding Information: Funding Supported by the NIH/NCI under award number P30CA016672. Dr. Mallet is funded by la fondation ARC pour la Recherche sur le Cancer. Conflicts of interest The authors have made the following disclosures: Harrys A. Torres is or has been the principal investigator for research grants from Gilead Sciences, Inc, and Merck & Company, Inc, with all funds paid to The University of Texas MD Anderson Cancer Center. He also is or has been a paid scientific advisor for Gilead Sciences, Inc, Merck & Company, Inc, and Dynavax Technologies; the terms of these arrangements are being managed by The University of Texas MD Anderson Cancer Center in accordance with its conflict-of-interest policies. Vincent Mallet is or has been a board member of Gilead Sciences, Inc, Merck & Company, Inc, and Abbvie; he has been a consultant for Translational Health Economics Network and Lingha Systems. Pooja Pundhir reports no conflicts of interest.",
year = "2019",
month = oct,
doi = "10.1053/j.gastro.2019.01.271",
language = "English (US)",
volume = "157",
pages = "909--916",
journal = "Gastroenterology",
issn = "0016-5085",
publisher = "W.B. Saunders Ltd",
number = "4",
}